相关实验视频
Updated: May 10, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.3K
早期低风险乳腺癌的IORT:从前性观察性研究的结果
Amalia Palacios-Eito1, María Del Carmen Moreno-Manzanaro1, María Espinosa-Calvo1
1Department of Radiation Oncology, Reina Sofia University Hospital. Avda. Menéndez Pidal s/n, 14004 Cordoba, Spain.
Clinical and translational radiation oncology
|July 14, 2025
概括
术内放射治疗 (IORT) 在现实世界使用中显示乳腺癌早期复发率较低. 比TARGIT-A试验更严格的标准可能会改善结果,年龄和利率是关键的风险因素.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 乳腺癌治疗方法 乳腺癌治疗方法
背景情况:
- 早期,低风险的乳腺癌治疗已出现显著的缓解.
- 术内放射疗法 (IORT) 提供了一种方便的单片剂疗法,但其最佳指示仍在争论中.
- TARGIT-A试验提供了关键数据,但实际的临床结果需要进一步调查.
研究的目的:
- 在现实临床环境中评估IORT的瘤结果.
- 评估IORT在乳腺癌治疗中的最佳指示.
- 为了比较IORT治疗患者的复发率和存活率.
主要方法:
- 这是一项前性,观察性,单中心研究,对464名接受IORT的患者进行了研究.
- 复制了TARGIT-A试验的实验分支,使用更严格的纳入标准.
- 主要终点:双侧乳腺复发 (IBR) 率;次要终点:生存率和复杂性.
主要成果:
- 估计的5年IBR风险为1.7%,在IORT+全乳房照射 (WBI) (1%) 和仅IORT (2.1%) 队列中较低.
- 5年整体生存率为97.6%,乳腺癌特异性生存率为99.5%.
- IBR的重大风险因素包括年轻年龄 (<50岁) 和接近/受影响的外科手术边缘. 没有报告的3-4级毒性;84%的优秀/良好的化品.
结论:
- 在所有IORT组中观察到较低的局部复发率.
- 应用比TARGIT-A试验更严格的标准可能会导致更好的结果.
- 为了验证这些发现,需要进行更长的随访.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

